Press release
Drugs for Benign Prostatic Hypertrophy Market 2020 By Segmentations, Key Company Profiles And Demand Forecasts to 2030 | TBRC Reports
Drugs for Benign Prostatic Hypertrophy Market
The global drugs for benign prostatic hypertrophy market is expected to decline from $4.6 billion in 2019 to $3.7 billion in 2020 at a compound annual growth rate (CAGR) of -18.7%. The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread. Currently there is less demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 6.2% from 2021 and reach $5.8 billion in 2023.
Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2594
The drugs for benign prostatic hypertrophy market consists of sales of benign prostatic hypertrophy drugs to treat enlarged prostate glands. Benign Prostatic Hypertrophy is commonly seen in men older than age 50.
Combination drugs are increasingly being used in the treatment of Benign Prostatic Hypertrophy as they are more effective and help prevent disease progression. A combination drug includes two or more active pharmaceutical ingredients (APIs) combined in a single dosage form. These drugs reduce the development of drug resistance, have fewer side effects and low treatment failure rate
Drugs for Benign Prostatic Hypertrophy Market Segmentation:
By Type
1.Alpha Blocker
2.5-alpha Reductase Inhibitor
3.Phosphodiesterase-5 Inhibitor and Others
By End User
1.Hospital Pharmacies
2.Retail Pharmacies and Others
Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report
Few Points From Table Of Content
1. Executive Summary
2. Drugs for Benign Prostatic Hypertrophy Market Characteristics
3. Drugs for Benign Prostatic Hypertrophy Market Size And Growth
4. Drugs for Benign Prostatic Hypertrophy Market Segmentation
5. Drugs for Benign Prostatic Hypertrophy Market Regional And Country Analysis
....
26. Key Mergers And Acquisitions In The Drugs for Benign Prostatic Hypertrophy Market
27. Drugs for Benign Prostatic Hypertrophy Market Trends And Strategies
28. Product Pipeline Analysis
29. Drugs for Benign Prostatic Hypertrophy Market Future Outlook and Potential Analysis
30. Appendix
The report covers the trends and market dynamics of the drugs for benign prostatic hypertrophy market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2594&type=smp
Some of the key players involved in the drugs for benign prostatic hypertrophy market are Allergan PLC, Astellas Pharma Inc., Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline PLC, Teva Pharmaceutical Industries Limited
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drugs for Benign Prostatic Hypertrophy Market 2020 By Segmentations, Key Company Profiles And Demand Forecasts to 2030 | TBRC Reports here
News-ID: 2139845 • Views: …
More Releases from The Business research company
Sake Market Size, Driving Growth, Rising Demand, Innovative Product Development …
The sake market size has grown strongly in recent years. It will grow from $9.28 billion in 2023 to $9.76 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to strong economic growth in emerging markets, expansion of online sales platforms and increasing consumer preference for beverages.
The sake market size is expected to see strong growth in the…
Technological Innovations and Growing Adoption Drive Rapid Expansion in the Prod …
The product lifecycle management market size has grown strongly in recent years. It will grow from $37.15 billion in 2023 to $39.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing demand for cloud-based product lifecycle management solutions, emerging markets growth, increased internet penetration, demographic shift, product innovation platforms and rising penetration of e-commerce.
The product lifecycle…
Driving Growth in Plastic Waste Management Market: Rising Awareness and Technolo …
The plastic waste management market size has grown steadily in recent years. It will grow from $37.36 billion in 2023 to $39.22 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to strong economic growth in emerging markets, corporate initiatives for plastic waste, technological advancements and an increased use of plastics across various industrial sectors.
The plastic waste management…
Outdoor Kitchen Appliances Market Trends: Surge in Demand Driven by Innovation a …
The outdoor kitchen appliances market size has grown strongly in recent years. It will grow from $6.33 billion in 2023 to $6.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increase in popularity of home renovations, increase in participation in outdoor activities, rise in trend of cookouts, and rise in…
More Releases for Benign
Benign Prostatic Hyperplasia Therapeutics Market Clinical Survey Report 2020
The Benign Prostatic Hyperplasia Therapeutics Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Click the link…
Benign prostatic hyperplasia: BPH drugs versus Dr Allen’s Device
The Global Treatment Market of Benign prostatic hyperplasia (BPH) was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2025.
Thermobalancing therapy with Dr Allen’s Device was patented by the United States Patent and Trademark Office. Over a decade, thousands of men with BPH used or are using this non-invasive and side-effects free Dr Allen’s Device.…
Cold Plasma Market Benign Rate by 2025
Global Cold Plasma Market: Snapshot
Cold plasma, additionally called non-warm plasma or non-balance plasma, is a sort of plasma—ordinarily known as the fourth condition of issue—which has gas particles show at direct temperature and electrons at moderately high temperatures. The properties of plasma have been widely looked into in the course of recent decades and an extensive number of front line utilizations of cold plasma innovation has exuded.
Cold plasma isn't in…
Benign Prostatic Hyperplasia Therapeutics Market Epidemiology Analysis, Therapy, …
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grants…
Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market
ReportsWorldwide has announced the addition of a new report title Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market to its growing collection of premium market research reports.
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices.
Topics Covered Include:
An overview of device-based and pharmacological therapies for BPH and prostatitis.
Global and country/region-specific market forecasts, including forecasts by product segment.
Competitive analyses…
Benign Prostatic Hyperplasia Therapeutics Development Pipeline Overview for H1 2 …
2017 Benign Prostatic Hyperplasia pipeline market report of on global industry analysis and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Benign Prostatic Hyperplasia (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010746
Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a…
